|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 3.825 USD | -0.39% |
|
+7.44% | +183.33% |
| 08-20 | Zentalis Pharmaceuticals Insider Bought Shares Worth $15,172,500, According to a Recent SEC Filing | MT |
| 08-17 | Zentalis Pharmaceuticals Closes Offering of Common Shares | MT |
| Market Cap | 362M 310M 290M 266M 499M 34.65B 505M 3.43B 1.34B 17.4B 1.36B 1.33B 57.57B | P/E 2026 * |
-1.76x | P/E 2027 * | -1.94x |
|---|---|---|---|---|---|
| Enterprise Value | 158M 135M 126M 116M 217M 15.08B 220M 1.49B 582M 7.57B 592M 579M 25.05B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.6x |
| Free-Float |
82.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | -0.39% | ||
| 1 week | +7.44% | ||
| Current month | -19.30% | ||
| 1 month | -23.65% | ||
| 3 months | -7.61% | ||
| 6 months | +58.06% | ||
| Current year | +183.33% |
| 1 week | 3.54 |  | 4.04 |
| 1 month | 3.49 | | 5.15 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.21 | | 6.95 |
| 3 years | 1.01 | | 27.51 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 2024-11-12 |
| Director of Finance/CFO | - | 2024-11-12 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-11-12 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 2022-05-15 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 2021-02-08 |
Jan Skvarka
BRD | Director/Board Member | 59 | 2022-09-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/14/26 | Buy | 4,335,000 | 4.5791% | |||
| 2/6/26 | Sell | Chief Technology Officer | 3,297 | 0.0046% | ||
| 2/6/26 | Sell | Chief Executive Officer | 8,755 | 0.0121% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | +7.44% | +104.55% | -84.99% | 364M | |
| -3.00% | +2.27% | +77.60% | +109.33% | 73.96B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 64.66B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 27.86B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.32B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 19.98B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.3B | |
| Average | +1.09% | +7.60% | +64.40% | +168.64% | 28.75B | |
| Weighted average by Cap. | +0.68% | +8.75% | +59.31% | +157.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 16.38M 14.03M 13.13M 12.02M 22.55M 1.57B 22.85M 155M 60.48M 787M 61.5M 60.16M 2.6B |
| Net income | -165M -142M -132M -121M -228M -15.82B -231M -1.57B -610M -7.94B -621M -607M -26.28B | -172M -147M -138M -126M -237M -16.47B -240M -1.63B -636M -8.27B -646M -632M -27.36B |
| Net Debt | -205M -175M -164M -150M -282M -19.57B -285M -1.94B -755M -9.83B -768M -751M -32.52B | -139M -119M -112M -102M -192M -13.34B -195M -1.32B -515M -6.7B -524M -512M -22.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$3.825 | -0.39% | 740,762 |
| 26-08-20 | US$3.840 | +0.52% | 1,570,856 |
| 26-08-19 | US$3.820 | +3.80% | 1,780,302 |
| 26-08-18 | US$3.680 | -0.67% | 1,201,439 |
| 26-08-17 | US$3.705 | +4.07% | 1,571,582 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
